HOFBF.US Hofseth BioCare ASA

Consumer Defensive Biotechnology USA Stocks
0.1183 USD
Close of Nov 14, 2026
0.1183 0.1666
Market cap
USD 59.9M
P/E
-
P/B
647.46x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is HOFBF.US undervalued?

Graham number

The Graham number of Hofseth BioCare ASA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hofseth BioCare ASA fundamental analysis

No fundamental analysis for Hofseth BioCare ASA yet.

Hofseth BioCare ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hofseth BioCare ASA

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and …

Full company profile